Where Bold Ideas Meet Insightful Dialogue
cmXp2 InterSect Asia features thought-provoking conversations with global experts as they explore game-changing innovations and strategies that drive progress in high-regulated sectors:
Food & Nutrition | Agriculture & Agri-food/Aquaculture | Life Sciences | Sustainability & ESG Compliance | Global Banking & Markets
Stay tuned for upcoming episodes!
Southeast Asia’s food and beverage industry is transforming fast – driven by health-conscious consumers and digital disruption. But scaling healthier, functional, and sustainable products comes with challenges: rising costs, taste expectations, regulatory hurdles, and the clean label push.
In this episode of cmXp2 Intersect Asia, Senior Partner Yashna Harjani shares practical insights on healthier product design, meeting cost and taste challenges, regulatory strategy, transparency with processed food, and use of stage-gate protocols and AI-tools to reduce innovation failure.
Catch the Clips
Southeast Asia’s food and beverage market is expanding in the health and wellness space.
Processed food stigma is real. Consumers want clean label products. Transparency may help win consumer trust.
Key food & beverage industry challenges & solutions.
Success in health & wellness space demands truly beneficial products, optimized pricing, and AI adoption.
[Episode 5] Michael J Sweeney:
Raising Capital: Why Asia's Agribusinesses Fall Short With International Investors
The global agriculture sector is forecasted to have an annual CAGR of 7-8% until 2033 with Asia driving nearly a third of that growth, particularly India and Southeast Asia. But Asia’s agriculture sector struggles to attract global investors.
To better understand the disconnect and pro-tip strategies to address the gap, Michael J Sweeney shares his insights and strategies to help agribusinesses. Michael has deep experience working with Asia agribusiness owners plan and achieve sustainable growth through tailored expertise in the areas of strategy, management, governance, sustainability, financial structuring and solutions.
Michael has served on Boards of Directors and Advisory Panels across multiple jurisdictions, including India, Vietnam, Australia, New Zealand, the Philippines, and Indonesia – bringing extensive experience in corporate governance and stakeholder management.
Catch the Clips
Asia's agri-businesses and farmers struggle to raise capital from international investors.
For Asia’s agribusinesses and farms, global institutional investors are special – they offer several strategic advantages.
What are the 2 X-factors for global institutional investors when deciding to invest?
[Episode 4] Dennis P Susay:
Southeast Asia's Steep Medical Inflation to Limit Access to Important Medical Innovative Treatments
Across Southeast Asia, steep medical inflation is now limiting patients’ access to breakthrough treatments. How will Life Sciences companies introduce innovative treatments, therapies, tests and devices?
Since 2021, it’s been double digit YOY medical trend costs growth and insurers expect this trend to continue until 2028. Governments, payors and insurers are cutting healthcare costs. Unfortunately, breakthrough treatments, therapies and tests will be ‘less received’ as payors prefer more cost-effective approaches.
In this episode of cmXp2 InterSect Asia, Life Sciences practice head, Dennis P Susay outlines the current impact of medical inflation on various stakeholders, and strategic considerations for Life Sciences companies when they seek to launch innovative and breakthrough treatments, tests and devices whilst governments and insurers are trimming costs and coverage. Much is at stake – as innovative medical breakthroughs are often expensive which means that patient access and adoption will be very low.
Catch the Clips
The deep impact of steep medical inflation upon Life Sciences & Healthcare, across Southeast Asia
Welcome to the era of Value-Based Healthcare and DRGs, with the intent to significantly reduce healthcare expenses.
Will Value-Based Healthcare KILL innovative Life Sciences companies in Southeast Asia, and ultimately patients' access to critical innovative treatments, tests and devices?
Is the path to precision medicine at risk?
Launching a breakthrough expensive treatment, test or device in Southeast Asia is really tough - with Value-Based Healthcare driving cost-reductions.
The scrutiny is on innovative (but expensive) treatments, tests and devices.
Four SIMPLE but GREAT examples of when medical breakthroughs delivered 'good value' against the backdrop of Value-Based Healthcare.
[Episode 3] Dr Regina Moench-Pfanner:
The Malnutrition Paradox: Hunger, Deficiencies & Overnutrition
Southeast Asia is grappling with the Triple Burden of Malnutrition – undernutrition, hidden hunger, and overnutrition – fueled by poor diets, rising urbanization, and persistent food insecurity. Women and adolescents remain among the most vulnerable, demanding focused, inclusive action.
In this episode of cmXp2 InterSect Asia, global nutrition expert, Dr Regina Moench-Pfanner talks about why nutrition must move beyond CSR and into the core of business strategy. She explores how solutions like food fortification, adolescent-focused programs, and public-private partnerships can make nutritious food affordable, accessible, and sustainable. With innovation and supportive policies, we can build resilient food systems that nourish both people and planet.
Catch the Clips
The Triple Burden of Malnutrition (TBM)
Food Fortification - To Combat Malnutrition
Solving the Malnutrition Crisis: It Takes All of Us!
[Episode 2] Dr Novriadi:
Is Asia’s Aquaculture Industry Heading in the Right Direction?
Aquaculture, a vital sustainable protein source, is projected to exceed USD 360.6 billion by 2032. Asia leads the global aquaculture market, producing over 90% of the world’s farmed seafood. What’s driving this rapid growth, and is the industry on the right path?
In this episode of cmXp2 InterSect Asia, leading aquaculture expert Dr Romi Novriadi explores the future of Asia’s aquaculture, uncovering key trends, challenges, and innovations that are reshaping the industry.
Catch the Clips
What’s driving the rapid growth in Asia's aquaculture?
What are the market restraints and challenges impacting the aquaculture industry (specifically in Asia)?
How can the industry strike a balance between productivity, sustainability, and animal welfare?
[Episode 1] Grace Cheah:
Southeast Asia Suppliers At Risk Of Losing International Clients
ESG Supply chain compliance is critical for Asia’s businesses – especially those supplying to their customers in the United States and Europe. In 2023, local and regional business media estimated that 80% of Southeast Asian suppliers stand to lose their existing EU and US clients because of ESG Supply Chain non-reporting.
In this episode of cmXp2 InterSect Asia, leading Sustainability and ESG Supply Chain compliance expert, Ms Grace Cheah outlines the required EU and US labor and emissions compliance requirements, the critical path required and key success factors for companies undertaking ESG Supply Chain compliance.
Catch the Clips
What are the consequences – if a supplier falls short with their ESG Supply Chain compliance reporting, when required by their EU or US clients?
What are the Labor requirements for suppliers, required by their EU and US clients – for ESG Supply Chain compliance?
What are the Big Three critical success factors for companies starting its ESG Supply Chain compliance journey?
For CEOs, what is the bottom line – Is ESG Supply Chain compliance actually important for their business?
Copyright © 2025-2026 cmXp2. All Rights Reserved.
All ‘information and materials’ (i.e. articles, presentations, videos and images) posted on this website may not be reproduced or used in any manner without the written permission of the copyright owner. For more information, please email: info@corpmediapl.com. The views and opinions expressed in all ‘information and materials’ posted on this website are those of the speakers and do not necessarily reflect the views or positions of any entities they represent. All data presented is accurate as of the published date of the ‘information and materials’. If unclear, please email: info@corpmediapl.com
